NYSE - Delayed Quote USD

Charles River Laboratories International, Inc. (CRL)

227.55 -2.54 (-1.10%)
At close: April 18 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,129,409.00
4,129,409.00
3,976,060.00
3,540,160.00
2,923,933.00
Cost of Revenue
2,626,853.00
2,626,853.00
2,513,409.00
2,205,522.00
1,850,392.00
Gross Profit
1,502,556.00
1,502,556.00
1,462,651.00
1,334,638.00
1,073,541.00
Operating Expense
885,295.00
885,295.00
811,676.00
744,776.00
640,812.00
Operating Income
617,261.00
617,261.00
650,975.00
589,862.00
432,729.00
Net Non Operating Interest Income Expense
-131,514.00
-131,514.00
-58,511.00
-73,258.00
-85,599.00
Other Income Expense
95,537.00
95,537.00
30,523.00
-35,894.00
99,984.00
Pretax Income
581,284.00
581,284.00
622,987.00
480,710.00
447,114.00
Tax Provision
100,914.00
100,914.00
130,379.00
81,873.00
81,808.00
Net Income Common Stockholders
474,624.00
474,624.00
486,226.00
390,982.00
364,304.00
Diluted NI Available to Com Stockholders
474,624.00
474,624.00
486,226.00
390,982.00
364,304.00
Basic EPS
9.27
--
9.57
7.77
7.35
Diluted EPS
9.22
--
9.48
7.60
7.20
Basic Average Shares
51,227.00
--
50,812.00
50,293.00
49,550.00
Diluted Average Shares
51,451.00
--
51,301.00
51,425.00
50,611.00
Total Operating Income as Reported
617,261.00
617,261.00
650,975.00
589,862.00
432,729.00
Total Expenses
3,512,148.00
3,512,148.00
3,325,085.00
2,950,298.00
2,491,204.00
Net Income from Continuing & Discontinued Operation
474,624.00
474,624.00
486,226.00
390,982.00
364,304.00
Normalized Income
474,624.00
474,624.00
486,226.00
390,982.00
364,304.00
Interest Income
5,196.00
5,196.00
780.00
652.00
834.00
Interest Expense
136,710.00
136,710.00
59,291.00
73,910.00
86,433.00
Net Interest Income
-131,514.00
-131,514.00
-58,511.00
-73,258.00
-85,599.00
EBIT
717,994.00
717,994.00
682,278.00
554,620.00
533,547.00
EBITDA
1,032,118.00
1,032,118.00
986,148.00
820,160.00
768,471.00
Reconciled Cost of Revenue
2,450,169.00
2,450,169.00
2,356,117.00
2,064,839.00
1,727,345.00
Reconciled Depreciation
314,124.00
314,124.00
303,870.00
265,540.00
234,924.00
Net Income from Continuing Operation Net Minority Interest
474,624.00
474,624.00
486,226.00
390,982.00
364,304.00
Normalized EBITDA
1,032,118.00
1,032,118.00
986,148.00
820,160.00
768,471.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 6/23/2000
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

ICLR ICON Public Limited Company
291.82
-0.07%
 
IQV IQVIA Holdings Inc.
227.17
-0.04%
 
MTD Mettler-Toledo International Inc.
1,192.56
-0.46%
 
IDXX IDEXX Laboratories, Inc.
477.79
-0.09%
 
DGX Quest Diagnostics Incorporated
125.91
-0.84%
 
WAT Waters Corporation
294.23
-3.27%
 
NOTV Inotiv, Inc.
4.7000
-13.28%
 
MEDP Medpace Holdings, Inc.
374.32
-2.12%
 
LH Laboratory Corporation of America Holdings
199.45
-0.26%
 
TMO Thermo Fisher Scientific Inc.
541.52
-1.05%